We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
(+1.3%)
Cap. Flow
-$819M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.06B |
| 2 |
UnitedHealth
UNH
|
+$935M |
| 3 |
Uber
UBER
|
+$426M |
| 4 |
Boeing
BA
|
+$312M |
| 5 |
Salesforce
CRM
|
+$309M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
Meta Platforms (Facebook)
META
|
+$644M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$628M |
| 4 |
GE Vernova
GEV
|
+$439M |
| 5 |
Eli Lilly
LLY
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.14% |
| 2 | Consumer Discretionary | 14.92% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 8.46% |
| 5 | Industrials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Kinetik
KNTK
$3.64B
| $768K | ﹤0.01% |
13,542
-36,223
| -73% | -$1.96M |
|
|
RVNC
1827
DELISTED
Revance Therapeutics, Inc.
RVNC
| $768K | ﹤0.01% |
252,468
-314,832
| -55% | -$1.37M |
|
1828
Arhaus
ARHS
$1.12B
| $763K | ﹤0.01% |
+81,195
| New | +$796K |
|
|
WOW
1829
DELISTED
WideOpenWest
WOW
| $763K | ﹤0.01% |
153,865
+75,539
| +96% | +$386K |
|
|
SNV
1830
DELISTED
Synovus
SNV
| $763K | ﹤0.01% |
+14,888
| New | +$771K |
|
1831
PUT
Invesco CurrencyShares Japanese Yen Trust
FXY
$426M
| $762K | ﹤0.01% |
13,000
-17,500
| -57% | -$1.06M |
|
1832
Bank OZK
OZK
$5.62B
| $762K | ﹤0.01% |
+17,101
| New | +$782K |
|
1833
Protagonist Therapeutics
PTGX
$8.8B
| $761K | ﹤0.01% |
19,716
-295,657
| -94% | -$12.9M |
|
1834
CALL
Intel
INTC
$435B
| $760K | ﹤0.01% |
37,900
-25,000
| -40% | -$564K |
|
1835
Ardmore Shipping
ASC
$669M
| $756K | ﹤0.01% |
62,230
-2,955
| -5% | -$40.2K |
|
|
HTLF
1836
DELISTED
Heartland Financial USA, Inc.
HTLF
| $754K | ﹤0.01% |
12,300
+600
| +5% | +$37.6K |
|
1837
Arcosa
ACA
$7.13B
| $753K | ﹤0.01% |
7,779
-103
| -1% | -$10.4K |
|
1838
Monro
MNRO
$537M
| $752K | ﹤0.01% |
+30,332
| New | +$831K |
|
1839
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $752K | ﹤0.01% |
+11,740
| New | +$772K |
|
1840
Tyra Biosciences
TYRA
$1.84B
| $752K | ﹤0.01% |
54,077
+34,463
| +176% | +$625K |
|
1841
Bio-Rad Laboratories Class A
BIO
$8.86B
| $749K | ﹤0.01% |
+2,279
| New | +$774K |
|
1842
Blackstone Secured Lending
BXSL
$5.43B
| $745K | ﹤0.01% |
23,050
-413,914
| -95% | -$12.9M |
|
|
NOTV
1843
DELISTED
Inotiv
NOTV
| $737K | ﹤0.01% |
+177,924
| New | +$536K |
|
1844
Kewaunee Scientific
KEQU
$102M
| $736K | ﹤0.01% |
+11,902
| New | +$485K |
|
|
1845
CALL
Salesforce
CRM
$149B
| $736K | ﹤0.01% |
+2,200
| New | +$702K |
|
1846
Arteris
AIP
$1.34B
| $734K | ﹤0.01% |
71,987
+29,299
| +69% | +$242K |
|
|
P
1847
Everpure Inc
P
$24.3B
| $731K | ﹤0.01% |
11,900
+7,064
| +146% | +$393K |
|
1848
Universal Technical Institute
UTI
$2.15B
| $730K | ﹤0.01% |
28,413
-50,556
| -64% | -$1.05M |
|
1849
Ero Copper
ERO
$2.67B
| $730K | ﹤0.01% |
+54,141
| New | +$917K |
|
1850
Utah Medical Products
UTMD
$226M
| $728K | ﹤0.01% |
11,850
+7,019
| +145% | +$454K |
|
Similar funds
Marshall Wace's Q4 2024 Portfolio in Review
As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
- Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
- Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
- Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
- Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
- Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.
Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.